These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 595602)

  • 21. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
    Hwang YS; Wang JL
    Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mexiletine in patients with progressive infarction and reduced ventricular function: anti-arrhythmic efficacy and hemodynamic effects].
    Zacà F; Ghinelli M; Bombardini T; De Collibus C; Zaccaria O; Steffanon L; Azzolini U; Valentini P; Puddu P
    G Ital Cardiol; 1990 Jun; 20(6):569-75. PubMed ID: 2227228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
    Koch G; Lindström B
    Eur J Clin Pharmacol; 1978 Jun; 13(4):237-40. PubMed ID: 352705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mexiletine for ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early interruption of antiarrhythmia treatment in the acute phase of infarction complicated by ventricular arrhythmia].
    Sebbah J; Khemache A; Gryman R; Farinotti R; Guérot C; Valère PE
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):129-32. PubMed ID: 4004087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mexiletine in ventricular arrhythmias--an assessment by 24 hours holter monitoring.
    Gambhir DS; Khalilullah M; Bahl VK
    Indian Heart J; 1984; 36(3):142-6. PubMed ID: 6490043
    [No Abstract]   [Full Text] [Related]  

  • 29. Mexiletine in clinical practice.
    Boyle DM
    Acta Cardiol Suppl; 1980; (25):137-45. PubMed ID: 6990665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short-and long-term therapy with Mexitil].
    Esser H; Kikis D
    Adv Clin Pharmacol; 1978; 16():169-86. PubMed ID: 356552
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mexitil in the treatment of arrhythmia].
    Modlińska J
    Wiad Lek; 1984 Jan; 37(2):133-5. PubMed ID: 6380116
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
    Menozzi C; Lolli G; Monducci I; Gheller G; Brignole M; Cattabiani ML; Vergoni W; Barone A
    Clin Ter; 1984 Feb; 108(3):199-208. PubMed ID: 6232057
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of an antiarrhythmic premedication on the development of premature ventricular contractions during fiberoptic gastroduodenoscopy.
    Pristautz H; Biffl H; Leitner W; Parsché P; Schmid P
    Endoscopy; 1981 Mar; 13(2):57-9. PubMed ID: 7227328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mexiletine: electrophysiologic effects].
    Rizzo A; Sisto F; Fiorilli R; Lisanti P
    G Ital Cardiol; 1983 Nov; 13(11):306-10. PubMed ID: 6667817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term treatment of ventricular arrhythmias with oral mexiletine.
    Campbell RW; Julian DG; Talbot RG; Prescott LF
    Postgrad Med J; 1977; 53 Suppl 1():146-9. PubMed ID: 406605
    [No Abstract]   [Full Text] [Related]  

  • 36. [Side effects after long-term administration of mexiletine].
    Henning B; Merx W; Brunner H; Härtel H
    Verh Dtsch Ges Inn Med; 1978; (84):742-7. PubMed ID: 742114
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical study of the ventricular anti-arrhythmia effects of oral and injectable mexiletine].
    Fauchier JP; Charbonnier B; Latour F; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1978; 27(2):173-8. PubMed ID: 655605
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
    Menozzi C; Brignole M; Monducci I; Lolli G; Vergoni W; Guiducci U; Bertulla A
    Clin Ter; 1982 Jan; 100(2):175-88. PubMed ID: 7186423
    [No Abstract]   [Full Text] [Related]  

  • 39. Long term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Shanks RG; Kelly JG; Adgey AA
    Postgrad Med J; 1977; 53 Suppl 1():143-5. PubMed ID: 406604
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy of mexiletine in the treatment of ventricular arrhythmia in patients with conduction disorders and sick sinus syndrome].
    González Zuelgaray J; Nieves E; Fernández R; Posse RA
    Medicina (B Aires); 1982; 42(5):483-7. PubMed ID: 7169943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.